At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 12 enrolled
Drug / intervention
Calcitrioldrug
Likely dose
Calcitriol 45 microgramsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study of the Effects of High-Dose Oral Calcitriol in Breast Cancer Patients Prior to Surgery
In Brief
A Phase 2 clinical trial evaluating Calcitriol for Breast Cancer. Completed, enrolled 12 participants across 1 site.
Detailed Summary
This research will examine the effectiveness of calcitriol in treating bone loss in women who are about to begin treatment for breast cancer. Twenty-five (25) subjects are expected to take part in this study. The investigators don't know if bone loss in breast cancer survivors should be treated differently than bone loss in other women.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2010
First PostedFeb 2011
Primary CompletionAug 2018
Study CompletionDec 2021
TodayJul 2026
First PostedFeb 10, 2011
Enrollment StartNov 1, 2010
Primary CompletionAug 1, 2018
Study CompletionDec 1, 2021
TodayJul 2, 2026
Enrollment to primary: 7.8 yearsPosted 15.4 years ago
Interventions
Calcitrioldrug
In pill form, 45 micrograms once a week for 12 weeks